OPCHNasdaqServices-Home Health Care ServicesUS GAAP · USD

Option Care Health, Inc.

Option Care Health is a U.S.-based provider of home and alternate-site infusion services delivered through a national network of locations. The company supplies infusion therapies, related pharmaceuticals, nursing support, and care coordination for patients with complex and chronic medical conditions, working under physician direction across the United States.

Revenue5,650m USD
+13.0 %y/y
Operating profit (EBIT)338m USD
+5.0 %y/y
EBIT margin6.0%
−0.5 ppy/y
Net income208m USD
−2.0 %y/y
Free cash flow217m USD
−24.5 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

02,0004,0006,000m USD2020: 3,033 m USD2020: EBIT 111 m USD20202021: 3,439 m USD2021: EBIT 191 m USD20212022: 3,945 m USD2022: EBIT 240 m USD20222023: 4,302 m USD2023: EBIT 315 m USD20232024: 4,998 m USD2024: EBIT 322 m USD20242025: 5,650 m USD2025: EBIT 338 m USD20255,650338
RevenueOperating profit (EBIT)

Business

Share of revenue
Infusion therapy services70 %

Administration of intravenous therapies in patients' homes or other nonhospital settings.

Pharmaceuticals and compounded solutions20 %

Medications and complex compounded products delivered as part of infusion care.

Nursing and clinical support10 %

Nursing visits, care coordination, and therapy management tied to infusion treatment.

Customers

Option Care Health serves patients needing infusion treatment for acute and chronic conditions, with care coordinated through physicians and other referral sources. Its business also depends on managed care organizations, third-party payers, hospitals, and pharmaceutical manufacturers that influence patient access, reimbursement, and therapy distribution.

Patients requiring infusion therapy

Patients receiving IV therapies at home or other nonhospital settings for chronic and acute conditions.

Managed care organizations and third-party payers

Payers that authorize, reimburse, and steer patient access to home infusion services.

Physicians and referral sources

Physicians, discharge planners, and hospital staff that refer patients into the service network.

Hospitals and health systems

Health systems that use the company for transitional and post-acute infusion care.

Pharmaceutical manufacturers

Drug makers that rely on the company for distribution, launch support, and adherence programs.

Strategy

The company’s strategy centers on expanding relationships with drug manufacturers, managed care organizations, and referral sources to secure access to new therapies and patient volume. It also uses its national footprint and clinical capabilities to support complex therapies, improve adherence, and strengthen its position in post-acute and home-based care pathways.

Maintain and expand manufacturer partnershipsShort term

Access to compatible therapies and launch opportunities supports patient volume and service breadth.

Grow payer and referral network coverageMedium term

Managed care and referral relationships determine patient access and service flow.

Broaden complex therapy capabilitiesMedium term

A wider therapy mix supports relevance across chronic and acute treatment categories.

Geography

Option Care Health operates primarily in the United States through a national network of locations across many states. Its footprint is designed to support local patient access, payer relationships, and referral coverage, while keeping the business exposed to U.S. reimbursement, regulatory, and healthcare utilization trends.

Risks

The business is exposed to payer reimbursement pressure, drug supply dependence, and concentration in managed care relationships, all of which can affect patient access and pricing. It also faces operational and compliance risks tied to cybersecurity, billing audits, inflation in labor and supplies, and the integration of acquisitions or strategic investments.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Payer reimbursement pressure1Dependence on compatible pharmaceuticals2Managed care concentration3Cybersecurity and privacy incidents4Billing audits and compliance reviews5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Payer reimbursement pressureImpact: HighLikelihood: High

    Managed care organizations and government payers can reduce reimbursement rates or change coverage rules.

    Exposure: Home infusion and specialty pharmacy reimbursement

  2. Dependence on compatible pharmaceuticalsImpact: HighLikelihood: Medium

    The business relies on manufacturers to supply drugs that fit home infusion administration requirements.

    ExposureDrug supplyRecallsFDA changesManufacturer strategy
  3. Managed care concentrationImpact: HighLikelihood: Medium

    Loss of key payer relationships could reduce patient referrals and access to covered lives.

    Exposure: MCO and third-party payer contracts

  4. Cybersecurity and privacy incidentsImpact: HighLikelihood: Medium

    The company stores protected health information and depends on secure IT systems for operations.

    ExposureHIPAA dataPatient recordsBilling systems
  5. Billing audits and compliance reviewsImpact: MediumLikelihood: Medium

    Government and private payer audits can lead to adverse findings, repayments, or operational changes.

    ExposureClaimsCodingReimbursement documentation

Accounting

Judgemental items
Revenue recognition and payer estimates

Revenue is recorded at estimated net realizable amounts, so reimbursement assumptions affect reported sales and receivables.

Impact: Net revenue and accounts receivable

Timing of pharmaceutical vs. nursing revenue

Drug delivery and service delivery are recognized at different points in time, affecting quarterly mix and comparability.

Impact: Quarterly revenue timing

Goodwill impairment

The company carries significant goodwill from acquisitions and tests it annually for impairment.

Impact: Potential non-cash impairment charges

Accounts receivable collectability

Payer mix and audit outcomes influence the collectability of billed amounts and reserve levels.

Impact: Bad debt and working capital

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026